ArticleKidney3602026
Proximal Tubule‑Derived Semaphorin 3C Promotes Fibrosis in Adenine-Induced Tubulointerstitial Nephritis.
Article in Kidney360, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
16 authors.
Funding
Abstract
key pointsProximal tubule‑derived semaphorin 3C functioned as a promoter of inflammation and fibrosis in adenine-induced tubulointerstitial nephritis. Semaphorin 3C acted on renal fibroblasts to enhance the expression of profibrotic markers and to promote proliferation. Thus, proximal tubule‑derived semaphorin 3C may represent a potential therapeutic target in tubulointerstitial nephritis.
backgroundSemaphorin 3C (SEMA3C) is a secreted protein that is essential for cardiovascular and renal development; however, its role in the development and progression of CKD remains unclear.
methodsWe performed immunostaining for SEMA3C in human and murine kidneys. Subsequently, tamoxifen-inducible proximal tubule‑specific Sema3c functional knockout mice ( Ndrg1CreERT2/+ ; Sema3cflox/flox , PT- Sema3c FKO) were generated using the clustered regularly interspaced short palindromic repeats-Cas9 technique. To evaluate the renoprotective effects of PT- Sema3c FKO, we used two well-established models of CKD: the adenine-induced tubulointerstitial nephritis model and high-fat diet/streptozotocin-induced diabetic nephropathy (DN) model.
resultsImmunostaining of human and murine kidneys showed high SEMA3C expression in the proximal tubules (PTs), particularly in human tubulointerstitial nephropathy. In adenine-induced tubulointerstitial nephritis, control (Ctrl) littermates ( Ndrg1+/+ ; Sema3cflox/flox ) showed increased Sema3c expression, whereas PT- Sema3c FKO mice exhibited markedly reduced Sema3c expression with attenuated fibrosis and inflammation. By contrast, in the high-fat diet/streptozotocin-induced DN model, renal Sema3c expression decreased in Ctrl mice after DN induction, and neither proteinuria nor fibrosis was ameliorated in PT- Sema3c FKO mice. In vitro , SEMA3C expression in PT cells was upregulated by TNF- α or TGF- β ; however, it was downregulated under glucotoxic conditions. SEMA3C stimulation of kidney fibroblasts induced profibrotic marker expression and proliferation.
conclusionsPT-derived SEMA3C promotes inflammation and fibrosis in adenine-induced tubulointerstitial nephritis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.